Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Quality control of serum and plasma by quantification of (4E,14Z)-sphingadienine-C18-1-phosphate uncovers common preanalytical errors during handling of whole blood

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. LDL-cholesterol versus glucose in microvascular and macrovascular disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Peripheral Neuropathy - time for better biomarkers?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Heterogeneity in subcellular muscle glycogen utilisation during exercise impacts endurance capacity in men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effect of insulin on natriuretic peptide gene expression in porcine heart

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. S100B and brain derived neurotrophic factor in monozygotic twins with, at risk of and without affective disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Xinyu Liu
  • Miriam Hoene
  • Peiyuan Yin
  • Louise Fritsche
  • Peter Plomgaard
  • Jakob S. Hansen
  • Christos T. Nakas
  • Andreas M. Niess
  • Jens Hudemann
  • Michael Haap
  • Maimuna Mendy
  • Cora Weigert
  • Xiaolin Wang
  • Andreas Fritsche
  • Andreas Peter
  • Hans Ulrich Häring
  • Guowang Xu
  • Rainer Lehmann
Vis graf over relationer

BACKGROUND: Nonadherence to standard operating procedures (SOPs) during handling and processing of whole blood is one of the most frequent causes affecting the quality of serum and plasma. Yet, the quality of blood samples is of the utmost importance for reliable, conclusive research findings, valid diagnostics, and appropriate therapeutic decisions. METHODS: UHPLC-MS-driven nontargeted metabolomics was applied to identify biomarkers that reflected time to processing of blood samples, and a targeted UHPLC-MS analysis was used to quantify and validate these biomarkers. RESULTS: We found that (4E,14Z)-sphingadienine-C18-1-phosphate (S1P-d18:2) was suitable for the reliable assessment of the pronounced changes in the quality of serum and plasma caused by errors in the phase between collection and centrifugation of whole blood samples. We rigorously validated S1P-d18:2, which included the use of practicality tests on 1400 randomly selected serum and plasma samples that were originally collected during single- and multicenter trials and then stored in 11 biobanks in 3 countries. Neither life-threatening disease states nor strenuous metabolic challenges (i.e., high-intensity exercise) affected the concentration of S1P-d18:2. Cutoff values for sample assessment were defined (plasma, 0.085 g/mL; serum, 0.154 g/mL). CONCLUSIONS: Unbiased valid monitoring to check for adherence to SOP-dictated time for processing to plasma or serum and/or time to storage of whole blood at 4 °C is now feasible. This novel quality assessment step could enable scientists to uncover common preanalytical errors, allowing for identification of serum and plasma samples that should be excluded from certain investigations. It should also allow control of samples before long-term storage in biobanks.

OriginalsprogEngelsk
TidsskriftClinical Chemistry
Vol/bind64
Udgave nummer5
Sider (fra-til)810-819
Antal sider10
ISSN0009-9147
DOI
StatusUdgivet - 1 maj 2018

ID: 55648983